|
WO2017021535A1
|
|
Improved cell culture medium for human progenitor cells (hpc)
|
|
EP3193894A1
|
|
Use of cord blood plasma to treat nk cell-mediated diseases and ifn- mediated diseases
|
|
EP3191583A1
|
|
Method for obtaining pancreatic beta cell surrogates by increasing pancreatic and duodenal homeobox 1 (pdx-1) expression
|
|
EP3169770A1
|
|
Methods for generating induced pluripotent stem cells
|
|
WO2015181253A1
|
|
Neural progenitor cell population
|
|
WO2015169994A1
|
|
Composition for modulating the activity of sidt1 for the treatment of ifn-mediated infectious, inflammatory or autoimmune diseases
|
|
WO2015036646A1
|
|
Combinations of aggregating proteins and molecular chaperone proteins for the treatment of proteinopathies or conformational diseases
|
|
EP3028052A1
|
|
Method for predicting treatment response and test for safe use of mesenchymal stem cells on inflammatory diseases.
|
|
EP3004331A1
|
|
Use of mesothelial cells in tissue bioengineering and artificial tissues
|
|
WO2014140218A1
|
|
Insulator to improve gene transfer vectors
|
|
WO2014122275A1
|
|
Method for the diagnosis and monitoring of autoinmune diseases
|
|
ES2536605A1
|
|
Method of obtaining megakaryocytes and platelets
|
|
ES2526816A1
|
|
Compositions for the treatment of liver damage
|
|
ES2523903A1
|
|
Method of obtaining useful data for the differential diagnosis of liver fibrosis
|
|
EP2792753A1
|
|
Method for obtaining data that can be used for the diagnosis and prognosis of neurosensory hypoacusis
|
|
ES2465766A1
|
|
SURGICAL CLAMP FOR APPROXIMATION AND REDUCTION OF BONE FRAGMENTS
|
